Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martin Rydziński
Observed names:
M Rydzinski,
Martin Rydzinski
Institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
Observed institution:
The Maria Sklodowska-Curie National Research Institute of Oncology
ORCID:
0009-0000-1005-0122
Observed ORCID:
0009-0000-1005-0122
OpenAlex ID:
A5064668642
Which tumour factors preclude organ preservation in patients with rectal cancer?
2023
·
Anna Hołdakowska
, Kamila Kurkowska
, et al.
·
Radiotherapy and Oncology
·
4
Image-guided high-dose-rate brachytherapy as the method of choice in medically inoperable early-stage endometrial cancer patients
2023
·
Martin Rydzinski
, Michal Bijok
, et al.
·
Gynecologic Oncology
·
4
The prognostic value of baseline 18FDG – Positron Emission Tomography – Computed Tomography in cervical cancer patients treated with definitive chemoradiotherapy – External multicentre validation model
2025
·
Emilia Staniewska
, Magdalena Stankiewicz
, et al.
·
Physics and Imaging in Radiation Oncology
·
2
PDF
664 Image-Guided Reirradiation for Recurrent Non-Endometrial Gynecologic Cancers: A Multi-Institutional Real-World Analysis
2026
·
Mateusz Bilski
, Federico Mastroleo
, et al.
·
Radiotherapy and Oncology
Reirradiation for recurrent uterine cancer: long-term outcomes, prognostic factors, and safety in a multi-institutional real-world cohort
2026
·
Mateusz Bilski
, Federico Mastroleo
, et al.
·
International Journal of Gynecological Cancer
37 Intracavitary brachytherapy as the method of choice in fragile patients with early-stage endometrial cancer
2021
·
A Rychlik
, M Rydzinski
, et al.
·
International Journal of Gynecological Cancer
PDF
Show more works
View as search
Works count:
6
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type